Ultrasound molecular imaging of E-Selectin in tumor vessels using poly n-butyl cyanoacrylate microbubbles covalently coupled to a short targeting peptide

Investigative Radiology

Volumn 48, Issue 12, 2013, Pages 843-850

  Fokong, Stanley ^a   Fragoso, Ana ^b   Rix, Anne ^a   Curaj, Adelina ^a   Wu, Zhuojun ^a   Lederle, Wiltrud ^a   Iranzo, Olga ^b   Gätjens, Jessica ^a   Kiessling, Fabian ^a   Palmowski, Moritz ^a,c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Angiogenesis; E selectin; Human ovarian carcinoma; Microbubbles; Molecular imaging; Ultrasound contrast agents

Indexed keywords

ENBUCRILATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROBUBBLE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; SHEAR STRESS; SOLID; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL LINE, TUMOR; DRUG CARRIERS; E-SELECTIN; ENBUCRILATE; FEMALE; MICE; MICE, NUDE; MICROBUBBLES; MOLECULAR IMAGING; OVARIAN NEOPLASMS; PEPTIDES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 84888201193     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31829d03ec     Document Type: Article

References (38)

1. Kiessling F, Fokong S, Koczera P, et al. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med. 2012;53:345-348.
2. Kiessling F, Huppert J, Palmowski M. Functional and molecular ultrasound imaging: concepts and contrast agents. Curr Med Chem. 2009;16:627-642.
3. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov. 2004;3:527-532. (Pubitemid 38807535)
4. Unnikrishnan S, Klibanov AL. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. AJR Am J Roentgenol. 2012; 199:292-299.
5. Hyvelin JM, Tardy I, Arbogast C, et al. Use of ultrasound contrast agent microbubbles in preclinical research: recommendations for small animal imaging. Invest Radiol. 2013;48:570-583.
6. Kiessling F, Bzyl J, Fokong S, et al. Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics. Curr Pharm Des. 2012;18: 2184-2199.
7. Kaufmann BA, Sanders JM, Davis C, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116:276-284. (Pubitemid 47196563)
8. Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104:2107-2112. (Pubitemid 33027054)
9. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischemic memory imaging with molecular echocardiography. Circulation. 2007;115:345-352. (Pubitemid 46151660)
10. Deshpande N, Lutz AM, Ren Y, et al. Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrastenhanced US. Radiology. 2012;262:172-180.
11. Wang H, Machtaler S, Bettinger T, et al. Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectintargeted US contrast agent: comparison with FDG PET/CT in a mouse model. Radiology. 2013.
12. Klibanov AL, Rychak JJ, Yang WC, et al. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging. 2006;1:259-266.
13. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883-899.
14. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674.
15. Hiller KM, Mayben JP, Bendt KM, et al. Transfection of alpha(1,3)- fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol Carcinog. 2000;27: 280-288. (Pubitemid 30191998)
16. Weston BW, Hiller KM, Mayben JP, et al. Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res. 1999; 59:2127-2135. (Pubitemid 29217676)
17. Biancone L, Araki M, Araki K, et al. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med. 1996;183:581-587. (Pubitemid 26060792)
18. van Wamel ACM, Hossack JA, Backer JM, et al. Molecular imaging with targeted contrast agents and high frequency ultrasound. Proc IEEE Ultrason Symp. 2007;961-964.
19. Martens CL, Cwirla SE, Lee RY, et al. Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem. 1995;270:21129-21136.
20. Renkonen R, Fukuda MN, Petrov L, et al. A peptide mimic of selectin ligands abolishes in vivo inflammation but has no effect on the rat heart allograft survival1. Transplantation. 2002;74:2-6. (Pubitemid 34779203)
21. Fukuda MN, Ohyama C, Lowitz K, et al. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res. 2000;60:450-456. (Pubitemid 30070775)
22. Pochon S, Tardy I, Bussat P, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol. 2010;45:89-95.
23. Anderson CR, Hu X, Zhang H, et al. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol. 2011;46:215-224.
24. Palmowski M, Morgenstern B, Hauff P, et al. Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging. Invest Radiol. 2008;43:162-169. (Pubitemid 351643142)
25. Chan WC, White PD. Fmoc solid phase peptide synthesis: a practical approach. Oxford University Press; 2000.
26. Fokong S, Siepmann M, Liu Z, et al. Advanced characterization and refinement of poly N-butyl cyanoacrylate microbubbles for ultrasound imaging. Ultrasound Med Biol. 2011;37:1622-1634.
27. Fokong S, Theek B, Wu Z, et al. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. J Control Release. 2012;163:75-81.
28. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767-804. (Pubitemid 23115023)
29. Anderson CR, Rychak JJ, Backer M, et al. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol. 2010;45:579-585.
30. Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology. 2008;246:508-518.
31. Rahman A, Kefer J, Bando M, et al. E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol. 1998;275:L533YL544.
32. Bettinger T, Bussat P, Tardy I, et al. Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species. Invest Radiol. 2012;47:516-523.
33. Myrset AH, Fjerdingstad HB, Bendiksen R, et al. Design and characterization of targeted ultrasound microbubbles for diagnostic use. Ultrasound Med Biol. 2011;37:136-150.
34. Paganelli G, Chinol M, Maggiolo M, et al. The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy. Eur J Nucl Med. 1997; 24:350-351. (Pubitemid 27165868)
35. Breitz HB, Weiden PL, Beaumier PL, et al. Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTAbiotin. J Nucl Med. 2000;41:131-140. (Pubitemid 30046695)
36. Guenther F, von zur Muhlen C, Ferrante EA, et al. An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions. Invest Radiol. 2010;45:586-591.
37. Koczera P, Wu Z, Fokong S, et al. Fluorescently labeled microbubbles for facilitating translational molecular ultrasound studies. Drug Deliv Transl Res. 2012;2:56-64.
38. Bzyl J, Palmowski M, Rix A, et al. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol. 2013;23:468-475.